Abstract
Preoperative diagnosis of papillary thyroid carcinoma (PTC) comprises numerous diagnostic procedures which are mostly applicable in tertiary institutions. Normal thyroid function depends on the presence of many trace elements and copper (Cu) and zinc (Zn) are some of those. The study is based on retrospective review of 118 patients with preoperatively diagnosed benign thyroid disease (BTD) and 12 with PTC, who underwent thyroid surgery at the Center for Endocrine Surgery Clinical Center of Serbia, Belgrade, between 2010 and 2012. The objective was to evaluate concentrations of Cu and Zn in serum as possible prediction markers for PTC in patients who underwent surgery for preoperatively diagnosed BTD. Concentrations of Cu and Zn ions in serum were measured using atomic absorption spectrophotometer. Data were analyzed using methods of descriptive statistics, Anova and t-test (p < 0.05 was considered statistically significant). Definitive pathohistological findings revealed PTC in 23 (19.5 %) and papillary microcarcinoma—mPTC in 13 (11.0 %) of BTD patients. The concentrations of Cu ions in serum of PTC patients as well as in serum of patients with mPTC were significantly higher than in serum of BTD patients (p < 0.05). The concentrations of Zn ions and Cu/Zn ratio in serum of PTC and mPTC patients were not significantly higher than in serum of BTD patients. The concentration of Cu ions in serum of patients before thyroid surgery can be useful, easy available, and a low-cost tool in prediction of preoperatively undiagnosed PTC in patients with BTD.
Similar content being viewed by others
References
Iyer NG, Shaha AR (2010) Management of thyroid nodules and surgery for differentiated thyroid cancer. Clin Oncol (R Coll Radiol) 22:405–412
Bozec A, Dassonville O, Chamorey E, Poissonnet G, Sudaka A, Peyrottes I, Ettore F, Haudebourg J, Bussière F, Benisvy D, Marcy PY, Sadoul JL, Hofman P, Lassale S, Vallicioni J, Demard F, Santini J (2011) Clinical impact of cervical lymph node involvement and central neck dissection in patients with papillary thyroid carcinoma: a retrospective analysis of 368 cases. Eur Arch Otorhinolaryngol 268:1205–1212
Arthur JR, Beckett GJ (1999) Thyroid function. British Medical Bulletin 55(3):658–668
Hetzel BS, Wellby ML (1997) Iodine. In: O’Dell BL, Sunde RA (eds) Handbook of nutritionally essential mineral elements. Marcel Delcker, New York, pp 557–581
Harris ED (2001) Copper homeostasis: the role of cellular transporters. Nutr Rev 59:281–285
Araya M, Pizarro F, Olivares M, Arredondo M, Gonzalez M, Mendez M (2006) Understanding copper homeostasis in humans and copper effects on health. Biol Res 39:183–187
Bonham M, Jacqueline M, Bernadette MH, Strain JJ (2002) The immune system as a physiological indicator of marginal copper status? British Journal of Nutrition 87:393–403
Tophanides T, Anastassopoulou J (2002) Copper and carcinogenesis. Crit Rev Oncol Hematol 42(1):57–64
Eide DJ (2006) Zinc transporters and the cellular trafficking of zinc. Biochim Biophys Acta 1763:711–722
Parisi AF, Vallee BL (1969) Zinc metalloenzymes: characteristics and significance in biology and medicine. Am J Clin Nutr 22:1222–1239
Civitareale D, Saiardi A, Falasca P (1994) Purification and characterization of thyroid transcription factor 2. Biochem 304:981–985
Wang D, Feng JF, Zeng P, Yang YH, Luo J, Yang YW (2011) Total oxidant/antioxidant status in sera of patients with thyroid cancers. Endocrine Related Cancer 18:773–782
Patel GS, Shah PJ (2005) TNM Staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin 55:242–258
Mulware SJ (2013) Trace elements and carcinogenicity: a subject in review. 3. Biotech 3(2):85–96
Cunzhi H, Jiexian J, Xianwen Z, Jingang G, Shumin Z, Lili D (2003) Serum and tissue levels of six trace elements and copper/zinc ratio in patients with cervical cancer and uterine myoma. Biol Trace Elem Res 94(2):113–122
Nasiadek M, Krawczyk T, Sapota A (2005) Tissue levels of cadmium and trace elements in patients with myoma and uterine cancer. Hum Exp Toxicol 24(12):623–630
Oyama T, Kawamoto T, Matsuno K, Osaki T, Matsumoto A, Isse T, Nakata S, Ozaki S, Sugaya M, Yasuda M, Yamashita T, Takenoyama M, Sugio K, Yasumoto K (2003) A case-case study comparing the usefulness of serum trace elements (Cu, Zn and Se) and tumor markers (CEA, SCC and SLX) in non-small cell lung cancer patients. Anticancer Res 23(1B):605–612
Garg AN, Singh V, Weginwar RG, Sagdeo VN (1994) An elemental correlation study in cancerous and normal breast tissue with successive clinical stages by neutron activation analysis. Biol Trace Element Res 46:185–202
Ng KH, Bradley DA, Looi LM, Mahmood CS, Wood AK (1993) Differentiation of elemental composition of normal and malignant breast tissue by instrumental neutron activation analysis. Appl Radiat Isot 44:511–516
Gerber M, Richardson S, Salkeld R, Chappuis P (1991) Antioxidants in female breast cancer patients. Cancer Invest 91:421–428
Cavallo F, Gerber M, Marrubini E (1991) Zinc and copper in breast cancer. Cancer 67:738–745
Zoboli A (1996) A case–control study on selenium, zinc and copper in plasma and hair of subjects affected by breast and lung cancer. Biol Trace Element Res 51:23–30
Sosa J, Bowman H, Tielsch J, Powe N, Gordon T, Udelsman R (1998) The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 228:320–330
Kucharzewski M, Braziewicz J, Majewska U, Gozdz S (2003) Copper, zinc and selenium in whole blood and thyroid tissue of people with various thyroid diseases. Biol Trace Element Res 93:9–18
Blazevicz A, Dolliver W, Sivsammye S, Deol A, Randhawa R, Orlicz-Szczesna G, Blazevicz R (2010) Determination of cadmium, cobalt, copper, iron, manganese and zinc in thyroid glands of patients with diagnosed nodular goitre using ion chromatography. Journal of Chromatography B 878:34–38
Przybylik-Mazurek E, Zagrodzki P, Kuzniarz-Ramarz S, Hubalewska-Dydejczyk A (2011) Thyroid disorders-assessments of trace elements, clinical and laboratory parameters. Biol Trace Element Res 141:65–75
Mittag J, Behrends T, Nordstrom K, Anselmo J, Vennstrom B, Schomburg L (2012) Serum copper as a novel biomarker for resistance to thyroid hormone. Biochem Journal 443(1):103–109
Golabek T, Darewicz B, Borawska M, Socha K, Markiewicicz R, Kudelski J (2012) Copper, zinc and Cu/Zn ratio in transitional cell carcinoma of the bladder. Urol Int 89(3):342–347
Mulware SJ (2013) Comparative trace elemental analysis in cancerous and noncancerous human tissues using PIXE. Journal of Biophysics doi:. doi:10.1155/2013/192026
Kosova F, Cetin B, Akinci M, Aslan S, Seki A, Pirhan Y, Ari Z (2012) Serum copper levels in benign and malignant thyroid diseases. Bratisl Lek Listy 113(12):718–720
Jeong D, Jeong Y, Park JH, Han SW, Kim SY, Kim YJ, Kim SJ, Hwangbo Y, Park S, Cho HD, Oh MH, Yang SH, Kim CJ (2012) BRAFV600E Mutation analysis in papillary thyroid carcinomas by peptide nucleic acid clamp real-time PCR. Ann Surg Oncol 20(3):759–766
Acknowledgments
The study was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia (projects 172051 and 175058).
Conflict of Interests
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dragutinović, V.V., Tatić, S.B., Nikolić-Mandić, S.D. et al. Copper as Ancillary Diagnostic Tool in Preoperative Evaluation of Possible Papillary Thyroid Carcinoma in Patients with Benign Thyroid Disease. Biol Trace Elem Res 160, 311–315 (2014). https://doi.org/10.1007/s12011-014-0071-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-014-0071-z